Abstract
Benzodiazepine (BZD) anxiolytics, through their activation of the BZD-GABA receptor complex, display robust anxiolytic-like effects following systemic administration in both conditioned and non-conditioned behavioral procedures. The present results show that the GABAA agonists muscimol (0.5–1.0 mg/kg), THIP (2.5–10.0 mg/kg), and isoguvacine (25.0 mg/kg) as well as the GABA transaminase (GABA-T) inhibitor AOAA (aminooxyacetic acid; 5.0–20.0 mg/kg) following intraperitoneal administration exert anxiolytic-like activity of similar magnitude to that of diazepam in two nonconditioned procedures, namely the social interaction and the elevated plus maze tests. We have also extended our original findings that the anti-epileptic drug sodium valproate exerts an anxiolytic-like effect in the Geller conflict paradigm, to show this agent's robust activity in the social interaction and elevated plus maze tests following systemic administration (100–400 mg/kg). These results show that GABAergic agents that facilitate GABA transmission are effective following systemic administration in non-conditioned anxiety procedures and may indicate potential therapeutic efficacy in certain anxiety states.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baraldi M, Grandison L, Guidotti A (1979) Distribution and metabolism of muscimol in the brain and other tissues of the rat. Neuropharmacology 18:52–62
Bormann J (1988) Electrophysiology of GABAA and GABAB receptor subtypes. 11:112–116
Bormann J, Clapham DE (1985) γ-Aminobutyrate acid receptor channels in adrenal chromaffin cells: a patch-clamp study. Proc Natl Acad Sci USA 82:2168–2172
Canunzi A, Costa E, Guidotti A (1980) Potentiation by intraventricular muscimol of the anticonflict effect of benzodiazepines. Brain Res 196:447–453
Cook L, Davidson AB (1973) Effects of behaviorally active drugs in a conflict-punishment procedure in rats. In: Grattini S, Mussini E, Randall LO (eds) The benzodiazepines. Raven Press, New York, pp 327–333
Cook L, Sepinwall S (1975) Behavioral analysis of the effects of mechanisms of action of benzodiazepines. In: Costa E, Greengard P (eds) Mechanism of action of benzodiazepines. Raven Press, New York pp 1–28
Costa E, Guidotti A (1979) Molecular mechanisms in the receptor action of benzodiazepine. Ann Rev Pharmacol Toxicol 18:531–545
Costall B, Kelly ME, Naylor RJ, Onaivi ES, Tyers MB (1989) Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behavior in the mouse. Br J Pharmacol 96:325–332
Csanalosi I, Schweizer E, Case WG, Rickels K (1987) Gepirone in anxiety: a pilot study. J Clin Psychopharmacol 7:31–33
Drugan R, Skolnick P, Paul S, Crawley J (1986) Low doses of muscimol produce anticonflict actions in the lateral system of the rat. Neuropharmacology 25:203–205
Dunn RW, Corbett R, Fielding S (1989) Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and elevated plus maze. Eur J Pharmacol 169:1–10
Dunn RW, Corbett R, Hubbard JW, Tobiasz P, Nordstrom LC, Carlezon WA, Cornfeldt ML, Fielding S (1990) The preclinical profiles of the 5-HT3 antagonists ondansetron, zacopride and MDL72222. J 4[3]:abstract 3161
Eison AS, Eison MS, Stanley M, Riblet LA (1986) Serotonergic mechanisms in the behavioral effects of buspirone and gepirone. Pharmacol Biochem Behav 22:237–241
File SE (1980) The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Methods 2:219–223
File SE, Johnston AL (1989) Lack of effects of 5-HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat. Psychopharmacology 99:248–251
Gardner C, Guy Y (1984) A social interaction model of anxiety sensitive to acutely administered benzodiazepines. Drug Dev Res 4:207–214
Gardner C, Piper D (1982) Effects of agents which enhance GABA-mediated neurotransmission on licking conflict in rats and exploration in mice. Br J Pharmacol 83:25–33
Geller I, Seifter J (1960) The effects of meprobamate, barbituates,d-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacologia 1:482–489
Goa KL, Ward A (1986) Buspirone: a preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic Drugs 32:114–129
Goldberg HL, Finnerty RJ (1979) The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Am J Psychiatry 136:1184–1187
Haefely W (1978) Central actions of benzodiazepines: General Introduction. Br J Psychiatry 133:231–238
Jones BJ, Costall B, Domeney AM, Kelly ME, Naylor RJ, Oakley NR, Tyers MB (1988) The potential anxiolytic activity of GR3832F, a 5-HT3 receptor antagonist. Br J Pharmacol 93:985–993
Kehne JH, Cassella JV, Davis M (1988) Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm. Psychopharmacology 94:8–13
Koe BK (1979) Biochemical effects of antianxiety drugs on brain monoamines, In: Fielding S, Lal H (eds) Anxiolytics, vol 3. Futura, New York, pp 173–195
Lal H, Shearman G, Fielding S, Dunn R, Kruse H, Theurer K (1980) Evidence that GABA mechanisms mediate the anxiolytic action of benzodiazepines. A study with valproic acid. Neuropharmacology 19:784–785
Loscher W (1982) Comparative assay of anticonvulsant and toxic potencies of sixteen GABA memetic drugs. Neuropharmacology 21:803–810
Maggi A, Enna SJ (1979) Characteristics of muscimol accumulation in mouse brain after systemic administration. Neuropharmacology 18:361–366
Paul SM, Marangos PS, Skolnick P (1981) The Benzodiazepine-GABA-chloride ionophore receptor complex: common site for minor tranquilizer action. Biol Psychiat 16:213–229
Pellow S, File SE (1986) Anxiolytic and anxiogenetic drug effects on exploratory activity in an elevated plus-maze: as novel test of anxiety in rat. Pharmacol Biochem Behav 24:525–529
Pellow S, Chopin P, File SE, Briley M (1985) Validation of open/closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:145–149
Rasmussen K, Schneider H, Petersen E (1981) Sodium valproate exerts anti-conflict activity in rats without any concomitant rise in forebrain GABA level. Life Sci 29:2163–2170
Rickels K, Weisman K, Norstad N, Singer M, Stoltz D, Brown A, Danton J (1982) Buspirone and diazepam in anxiety: a controlled study. J Clin Psychiatry 43:81–86
Sanger DJ (1985) GABA and the behavioral effects of anxiolytic drugs. Life Sci 36:1503–1513
Scheel-Kruger J, Petersen E (1982) Anticonflict effects of the benzodiazepine mediated by a GABAergic mechanism in the amygdala. Eur J Pharmacol 82:115–116
Sepinwall J, Cook L (1980) Relationship of γ-aminobutyric acid (GABA) to antianxiety effects of benzodiazepines. GABA neurotransmission. Brain Res Bull 5:839–848
Shephard RA, Toal L, Leslie JC (1990) Effects of agonists and antagonists at the GABA/benzodiazepine receptor on conditioned suppression in rats. Pharmacol Biochem Behav 36:39–43
Sullivan J, Sepinwall J, Cook L (1978) Anticonflict evaluation of muscimol, a GABA receptor agonist alone and in combination with diazepam. Fed Proc 37:619–622
Study RE, Barker JL (1981) Diazepam and (-)-pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of γ-aminobutyric acid responses in cultured central neurons. Proc Natl Acad Sci USA 78:7180–7184
Vellucci S, Webster R (1984) The role of GABA in the anticonflict action of sodium valproate and chlordiazepoxide. Pharmacol Biochem Behav 21:845–851
Vogel J, Beer B, Clody D (1971) A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia 21:1–7
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Corbett, R., Fielding, S., Cornfeldt, M. et al. GABAmimetic agents display anxiolytic-like effects in the social interaction and elevated plus maze procedures. Psychopharmacology 104, 312–316 (1991). https://doi.org/10.1007/BF02246029
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246029